Re-hospitalisation After Transcatheter Aortic Valve Implantation

Re-hospitalisation After Transcatheter Aortic Valve Implantation

The goal of this study is to investigate whether patient-tailored follow-up for patients treated with transcatheter aortic valve implantation (TAVI) can prevent re-hospitalisation and improve quality of life compared with the standard follow-up program.

The rationale of this study is the persistently high rate of re-hospitalisation after TAVI, which increases the risk of mortality and diminishes the patient-evaluated quality of life. Our hypothesis is that patient-tailored follow-up for patients treated with TAVI will reduce the rate of re-hospitalisation after the TAVI-procedure and improve quality of life.

The primary endpoints are the rate of re-hospitalisation within 90 days of the procedure and quality of life adjusted life years at 90-day follow-up.

Inclusion Criteria:

• Patients who underwent technical successful TAVI
• Residing in Denmark
• Provided written informed consent

Exclusion Criteria:

• Index admission mortality
• Index admission conversion to open surgery
• Age < 18 years
• Women of childbearing potential, pregnant or nursing